Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YANAGITA, M.
Right arrow Articles by DOI, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YANAGITA, M.
Right arrow Articles by DOI, T.
J Am Soc Nephrol 10:2503-2509, 1999
© 1999 American Society of Nephrology

Mechanism of Inhibitory Effect of Warfarin on Mesangial Cell Proliferation

MOTOKO YANAGITA*, KENJI ISHII*, HARUNOBU OZAKI*, HIDENORI ARAI*, TORU NAKANO{ddagger}, KAZUMASA OHASHI§, KENSAKU MIZUNO§, TORU KITA* and TOSHIO DOI{dagger}

* Department of Geriatric Medicine, Graduate School of Medicine, Faculty of Medicine, Kyoto University, Kyoto, Japan
{dagger} Division of Artificial Kidneys, Kyoto University, Kyoto, Japan
{ddagger} Discovery Research Laboratory, Shionogi and Co., Ltd., Japan
§ Department of Biology, Faculty of Science, Kyushu University, Kyushu, Japan.

Correspondence to Dr. Kenji Ishii, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyoku, Kyoto 606-8507, Japan. Phone: +81 75 751 3465; Fax: +81 75 751 3574; E-mail: kishii{at}kuhp.kyoto-u.ac.jp

Abstract. Because proliferation of mesangial cells is a hallmark of glomerular diseases, understanding the regulatory mechanism of mesangial proliferation is important for the treatment. Warfarin has long been used to treat glomerular diseases, although its mechanism of effect on mesangial proliferation has remained unknown. Therefore, this study was conducted to examine whether warfarin can inhibit mouse mesangial cell proliferation by focusing on Gas6, which has been shown to be activated by vitamin K-dependent {gamma}-carboxylation. In mesangial cells, Gas6 and its receptor Axl were expressed. In addition, exogenous Gas6 phosphorylated Axl, activated extracellular signal-regulated kinase, and stimulated [3H]-thymidine incorporation in mouse mesangial cells. This study also examined whether endogenous Gas6 stimulates mesangial proliferation. Conditioned medium (CM) from serum-starved mesangial cells could stimulate [3H]-thymidine incorporation and phosphorylate extracellular signal-regulated kinase, whereas CM in the presence of warfarin could not. Simultaneous administration of vitamin K could cancel the inhibitory effect of warfarin. These results suggest that vitamin K-dependent growth factors in the CM are critical for mesangial proliferation. Addition of the extracellular domain of Axl to the CM inhibited its mitogenic effect on mesangial cells, suggesting that this vitamin K-dependent growth factor is Gas6. It is concluded that Gas6 is an endogenous mitogen in mesangial cells, and warfarin inhibits mesangial proliferation possibly by inhibiting {gamma}-carboxylation of Gas6. This study sheds light on the regulation of mesangial proliferation and may lead to a new therapeutic strategy for glomerular diseases.




This article has been cited by other articles:


Home page
 HypertensionHome page
V. A. Korshunov, M. Daul, M. P. Massett, and B. C. Berk
Axl Mediates Vascular Remodeling Induced by Deoxycorticosterone Acetate Salt Hypertension
Hypertension, December 1, 2007; 50(6): 1057 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
V. Budagian, E. Bulanova, Z. Orinska, E. Duitman, K. Brandt, A. Ludwig, D. Hartmann, G. Lemke, P. Saftig, and S. Bulfone-Paus
Soluble Axl Is Generated by ADAM10-Dependent Cleavage and Associates with Gas6 in Mouse Serum
Mol. Cell. Biol., November 1, 2005; 25(21): 9324 - 9339.
[Abstract] [Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
M. Bern
Observations on Possible Effects of Daily Vitamin K Replacement, Especially Upon Warfarin Therapy
JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 388 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. R. van Ginkel, R. L. Gee, R. L. Shearer, L. Subramanian, T. M. Walker, D. M. Albert, L. F. Meisner, B. C. Varnum, and A. S. Polans
Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival
Cancer Res., January 1, 2004; 64(1): 128 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Nagai, H. Arai, M. Yanagita, T. Matsubara, H. Kanamori, T. Nakano, N. Iehara, A. Fukatsu, T. Kita, and T. Doi
Growth Arrest-specific Gene 6 Is Involved in Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy
J. Biol. Chem., May 9, 2003; 278(20): 18229 - 18234.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Yanagita, H. Arai, T. Nakano, K. Ohashi, K. Mizuno, A. Fukatsu, T. Doi, and T. Kita
Gas6 Induces Mesangial Cell Proliferation via Latent Transcription Factor STAT3
J. Biol. Chem., November 2, 2001; 276(45): 42364 - 42369.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Yanagita, H. Arai, K. Ishii, T. Nakano, K. Ohashi, K. Mizuno, B. Varnum, A. Fukatsu, T. Doi, and T. Kita
Gas6 Regulates Mesangial Cell Proliferation through Axl in Experimental Glomerulonephritis
Am. J. Pathol., April 1, 2001; 158(4): 1423 - 1432.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673